PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.550
+0.130 (9.15%)
Aug 13, 2025, 3:58 PM - Market open
Paramount Global Market Cap
PMV Pharmaceuticals has a market cap or net worth of $82.14 million as of August 13, 2025. Its market cap has decreased by -5.53% in one year.
Market Cap
82.14M
Enterprise Value
-72.04M
1-Year Change
-5.53%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $82.14M, a decrease of -94.91%. That is a compound annual growth rate of -45.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 75.25M | -3.70% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
| Sep 25, 2020 | 1.61B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 591.28B |
| Johnson & Johnson | 418.83B |
| AbbVie | 354.09B |
| UnitedHealth Group | 245.41B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.82B |
| Novo Nordisk | 223.00B |